Abstract

Central MessageLate outcomes of uncomplicated type B dissection and Intramural hematoma are somewhat different. A proposed therapeutic attitude is needed.See Article page 1192. Late outcomes of uncomplicated type B dissection and Intramural hematoma are somewhat different. A proposed therapeutic attitude is needed. See Article page 1192. In this issue of the Journal, Sailer and coworkers1Sailer A.M. Nelemans P.J. Hastie T.J. Chin A.S. Huininga M. Chiu P. et al.Prognostic significance of early aortic remodeling in acute uncomplicated type b aortic dissection and intramural hematoma.J Thorac Cardiovasc Surg. 2017; 154: 1171-1172Abstract Full Text Full Text PDF Scopus (25) Google Scholar report, through a study of the 1-, 2-, and 5-year evolution of uncomplicated type B aortic dissection (AD) and intramural hematoma (IMH), on a very interesting but rarely addressed matter of importance concerning the follow-up and the possible late treatment of these aortic syndromes. The article is very well organized and quite clearly written, and the information provided seems to be in line with what can be observed through daily practice or intuitively guessed. The authors define 3 groups of evolution for the initially uncomplicated type B AD and 2 groups for type B IMH, in which the risk of late adverse events is quite different. They show that adverse events in IMH occurred mostly during the first year and at a low rate, whereas in type B AD the cumulative probability of adverse events continued to increase gradually over time during the entire follow-up period. Thus, as it stands, this study seems perfectly contributory, providing good and useful information. Not totally, however. Indeed, one important point is not addressed. The authors do not specify their actual therapeutic attitude when observing the evolution of the various groups. What was the mode and the frequency of the surveillance during follow-up? What is the optimal medical treatment, and when should surgery or thoracic endovascular aneurysm repair (TEVAR) be proposed? It is somewhat understandable that a long, extensive description of the medical and surgical or interventional treatments performed during follow-up could distract the reader from the main purpose of the study. Nevertheless, such information may be of importance if one wants to reduce the rates of adverse events, particularly the most deleterious ones. Because adverse events rarely manifest during the first year in IMH, should computed tomography (CT) scanning be performed regularly during this period—for instance at discharge and then at 3, 6, and 12 months thereafter? If the IMH resolves, should surveillance be waived? In uncomplicated chronic type B AD, should a CT scan or any other suitable imaging be performed regularly throughout follow-up? The most important unresolved question whether in cases of increasing aortic diameter, when is surgical or interventional treatment indicated? The answer is clear in patients with severe occurring or impending adverse events, such as rupture, malperfusion, recurring severe pain—but what about totally asymptomatic patients? Performing open surgery and possibly TEVAR in an asymptomatic, physically and socially active patient is a difficult decision, considering that such surgery can involve devastating complications, such as paraplegia or even death. Alluding to this problem, the authors discuss the various US and European guidelines. However, this does not shed much light on the matter, because guidelines differ somewhat and are modified from time to time, clearly demonstrating that they are only recommendations and not strong obligations. Therefore, considering the very important cohorts studied in the present report, it would have been helpful had the authors shared their present approach and explained whether the analysis of those cohorts had led them to modify their practice. Let's hope that they will in a future study on the same cohorts of patients satisfy this requirement of the readership and share their experience. Prognostic significance of early aortic remodeling in acute uncomplicated type B aortic dissection and intramural hematomaThe Journal of Thoracic and Cardiovascular SurgeryVol. 154Issue 4PreviewPatients with Stanford type B aortic dissections (ADs) are at risk of long-term disease progression and late complications. The aim of this study was to evaluate the natural course and evolution of acute type B AD and intramural hematomas (IMHs) in patients who presented without complications during their initial hospital admission and who were treated with optimal medical management (MM). Full-Text PDF Open Archive

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call